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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYTheNAD-dependent deacetylase SIRT1 is involved in chromatin silencing and genome stability. Elevated SIRT1 levels in embryonic stem
cells also suggest a role for SIRT1 in pluripotency. Murine SIRT1 attenuates telomere attrition in vivo and is recruited at telomeres in
induced pluripotent stem cells (iPSCs). Because telomere elongation is an iPSC hallmark, we set out to study the role of SIRT1 in
pluripotency in the setting of murine embryonic fibroblasts reprogramming into iPSCs. We find that SIRT1 is required for efficient post-
reprogramming telomere elongation, and that this effect is mediated by a c-MYC-dependent regulation of the mTert gene. We further
demonstrate that SIRT1-deficient iPSCs accumulate chromosomal aberrations and show a derepression of telomeric heterochromatin.
Finally, SIRT1-deficient iPSCs form larger teratomas that are poorly differentiated, highlighting a role for SIRT1 in exit from pluripotency.
In summary, this work demonstrates a role for SIRT1 in the maintenance of pluripotency and modulation of differentiation.INTRODUCTION
SIRT1 belongs to the sirtuin family of NAD+-dependent
lysine deacetylases, homologs of the yeast protein Sir2. In
mammals, the sirtuin family includes seven members
(SIRT1–SIRT7), with SIRT1 having the closest homology
to Sir2. SIRT1 has been shown to regulate several key
cellular processes, among them chromatin remodeling,
transcriptional silencing, and genomic stability (Haigis
and Sinclair, 2010), via the deacetylation of diverse sub-
strates, including p53 (Cheng et al., 2003), FoxO transcrip-
tion factors (Frescas et al., 2005), and NF-kB (Yeung et al.,
2004).
Sir2 is part of the Sir silencing complex, which counter-
acts aging in yeast by suppressing recombination at the
ribosomal DNA locus, and contributes to heterochromatin
formation (Sinclair and Guarente, 1997). Importantly,
the Sir silencing complex is also involved in the forma-
tion and maintenance of telomeric heterochromatin in
budding yeast (Xu et al., 2007).
Telomeres are specialized nucleoprotein structures that
protect the ends of eukaryotic chromosomes from un-
scheduled DNA repair (Chan and Blackburn, 2004). In ver-
tebrates, telomeres are constituted by TTAGGG tandem
repeats, bound by a specialized multiprotein complex,
known as shelterin, which plays a pivotal role in the regula-
tion of telomere length and protection of chromosome
ends (de Lange, 2005). Telomeric repeats are synthesized
by telomerase (Greider and Blackburn, 1985), a ribonucleo-
protein reverse transcriptase expressed mainly during
embryonic development, as well as in adult stem cell com-
partments (Flores et al., 2006a; Liu et al., 2007). Telomerase690 Stem Cell Reports j Vol. 2 j 690–706 j May 6, 2014 j ª2014 The Authorslevels in adult somatic cells are not sufficient to prevent the
telomere shortening that occurs with aging, and telomeres
suffer a progressive attrition with cell divisions.
Chromatin at mammalian telomeres is underacetylated
and shares the typical features of other repeat-containing
constitutive heterochromatic elements, such as pericen-
tric chromatin. Telomeric repeats are also enriched for
H3K9me3, which represents a docking site for the binding
of HP1 isoforms (Benetti et al., 2007).
Despite evidence that telomeres are heterochromatic
structures, our group and others have reported that the
C-rich strand of eukaryotic telomeres is transcribed by
RNA polymerase II, giving rise to noncoding transcripts,
heterogeneous in size, known as TelRNAs or TERRAs
(Azzalin et al., 2007; Schoeftner and Blasco, 2008). TERRAs
closely associate with telomeres and negatively regulate
telomerase activity in vitro (Schoeftner and Blasco, 2008).
Telomeric RNA abundance is modulated by several factors,
including telomere length; consistently, TERRA transcrip-
tion increases upon somatic cell reprogramming (Marion
et al., 2009).
Murine and human somatic cells can be reprogrammed
into induced pluripotent stem cells (iPSCs) by the overex-
pression of exogenous transcription factors related to
pluripotency, namely OCT4, KLF4, SOX2, and c-MYC
(Takahashi and Yamanaka, 2006). During murine iPSC
generation, telomeres are also ‘‘reprogrammed’’ to adopt
features similar to those of embryonic stem cells (ESCs);
iPSC telomere length increases in a telomerase-dependent
manner, and this elongation continues with cell passages
after reprogramming, until they reach a length comparable
to that of ESCs (Marion et al., 2009). In addition, there is an
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et al., 2013), and the global epigenome is broadly rear-
ranged to an ESC-like chromatin architecture (Meshorer
et al., 2006). Therefore, besides stemness and pluripotency
factors, cellular reprogramming also involves chromatin
modifiers that contribute to the remodeling of chromatin,
including telomere chromatin.
SIRT1 is highly expressed in mouse ESCs, and its expres-
sion progressively declines during in vitro differentiation
(Calvanese et al., 2010). This downregulation is required
to correctly establish differentiation programs, pointing
to SIRT1 as a pluripotency and differentiation modulator.
Given this, it is conceivable that SIRT1 may play a role in
some of the events occurring during somatic cell reprog-
ramming. We therefore set out to study the role of SIRT1
in this process and to analyze its role in the dynamic
changes that telomeres undergo during reprogramming.
To address this, we employed both loss-of-function
(Sirt1/) (Cheng et al., 2003) and gain-of-function
(Sirt1Super) (Pfluger et al., 2008) mouse models. We gener-
ated iPSCs from Sirt1/ and Sirt1Super murine embryonic
fibroblasts (MEFs), together with their wild-type counter-
parts, and investigated the impact on reprogramming
of SIRT1 deficiency or mild overexpression. Our results
show that SIRT1, although not strictly required for reprog-
ramming itself, is necessary for telomere elongation after
reprogramming; this effect is mediated by the regulation
of telomerase expression via c-MYC. In addition, SIRT1 is
required to maintain iPSC genomic stability and is
involved in telomeric transcription and in the remodeling
of telomeric chromatin.
In conclusion, this work demonstrates a role for SIRT1 in
regulating some of the hallmark features of iPSCs, namely
genomic integrity and telomere expansion. Understanding
the molecular mechanism by which such characteristics
are maintained in established iPSC lines is critical to the
advance of iPSC technology in regenerative medicine.RESULTS
Reprogramming Efficiency of Sirt1/ and Sirt1Super
Embryonic Fibroblasts
Wefirst asked if SIRT1 plays a direct role in the conversionof
fibroblasts to the pluripotent state. We infected wild-type
(Sirt1+/+), SIRT1-deficient (Sirt1/), or SIRT1-overexpressing
(Sirt1Super) MEFs with retroviral vectors expressing the three
reprogramming factors (OCT4,KLF4, andSOX2) togenerate
iPSCs. We estimated reprogramming efficiency on the basis
of the number of colonies positive for alkaline phosphatase
staining, normalized to the percentage of infected cells (Fig-
ures 1A–1D). Sirt1/, as well as Sirt1Super MEFs, showed a
reprogrammingefficiencycomparable towild-typecounter-Steparts, indicating that SIRT1 does not impact the overall abil-
ity of the cells to be induced to a pluripotent state. The
percentage of colonies stainingpositive forNANOG(Figures
1E and 1F), as well as NANOG andOCT3/4 protein levels in
individual passage 5 iPSC clones (Figures 1G and1H; Figures
S1A and S1B available online), also revealed no differences
in reprogramming efficiencies among genotypes.
To more stringently test their pluripotency features, we
injected Sirt1/ and Sirt1Super iPSCs into C57BL/6-Tyrc
(albino) blastocysts or aggregated them with CD1 (albino)
morulae. For both Sirt1+/+ and Sirt1/ iPSCs, we obtained
black-haired chimeras with a variable extent of chimerism
(Figure 1I). Sirt1Super iPSCs also generated chimeras similar
to their wild-type counterparts (Figure 1J), suggesting that
both SIRT1-deficient and SIRT1-overexpressing iPSCs can
contribute to the formation of adult tissues.
Interestingly, previous results showed that SIRT1 is
highly expressed in ESCs compared to differentiated cells
(Calvanese et al., 2010). We therefore tested whether
SIRT1 expression is also induced during reprogramming.
Remarkably, we found that the expression of SIRT1, which
is very low in parental MEFs, is increased in iPSCs compara-
ble to levels seen in ESCs (Figure S1C).
SIRT1 Deficiency Correlates with a Delayed
Differentiation In Vivo
To test the in vivo differentiation potential of SIRT1-
deficient iPSCs, we injected Sirt1+/+ and Sirt1/ iPSCs in
athymic nude mice and screened the formation of subcu-
taneous teratomas. All the three germ layers could be found
in teratomas derived from both Sirt1+/+ and Sirt1/ iPSCs
(Figure 2B). Interestingly, teratomas from Sirt1/ iPSCs
grew much faster, resulting in significantly bigger tumors,
compared to those obtained from Sirt1+/+ iPSCs (Figure 2A
and inset). This difference was most significant when
comparing the final xenograft weights at the end of the
experiment (Figure 2C) or the average xenograft volumes
throughout the experiment (Figure 2D).
One explanation for the increased size of Sirt1/ tera-
tomas could be an enhanced intrinsic cell proliferation
capacity in undifferentiated Sirt1/ iPSCs, as reported in
other cell types (Chua et al., 2005; Narala et al., 2008). To
test this, we measured the proliferation rate of three inde-
pendent clones per genotype over 5 days and found com-
parable values for all clones, ruling out this possibility
(Figure S1D).
An alternative explanation for the enhanced growth of
Sirt1/ teratomas is that Sirt1/ iPSCs may acquire a pro-
liferative advantage while differentiating, because it has
been previously reported that SIRT1 dually modulates
differentiation and proliferation in mouse neurospheres
(Hisahara et al., 2008) and human keratinocytes (Blander
et al., 2009). Because teratomas are mainly composed ofm Cell Reports j Vol. 2 j 690–706 j May 6, 2014 j ª2014 The Authors 691
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SIRT1 and Telomere Elongation upon Reprogrammingectodermal tissues, we reasoned that SIRT1 deficiency
could delay ectodermal differentiation, allowing Sirt1/
iPSCs tomaintain longer their stemness properties and pro-
liferate more than the wild-type cells.
To verify this hypothesis, we microinjected Sirt1+/+ and
Sirt1/ iPSC clones (n = 3 each) in athymic nude mice and
monitored early events by removing the tumors 14 days
after injection. At this stage, Sirt1+/+ xenografts just started
to become visible, whereas Sirt1/ tumors were already
appreciably larger. We stained a section from each tumor
(n = 3 per genotype) for the proliferation marker phospho-
histone 3 (P-H3; Figures 2E and 2F) and, as expected, we
observed a higher number of proliferating cells in Sirt1/
teratomas compared to wild-type. We next quantified the
number of cells positive for the stemness marker OCT3/4
and for NESTIN, a neural lineage precursormarker. Interest-
ingly, Sirt1/ teratomas exhibited a higher number of cells
expressing OCT3/4 (Figures 2G and 2H) and a consistently
weaker NESTIN staining compared to wild-type xenografts
(Figures 2I and 2J). No differences were observed in tera-
tomas examined at later stages (data not shown).
To corroborate this observed effect in a different setting,
we generated embryoid bodies (EBs) from four clones of
each Sirt1+/+ and Sirt1/ iPSCs in culture and assessed
OCT4 and NESTIN levels at different time points (day 7,
day 14, and day 21 after leukemia inhibitory factor [LIF]
was withdrawn) through immunohistochemistry (Figures
S2A and S2B, representative images). After 7 days, we could
observe a higher number of OCT4-positive cells and a clear
tendency for decreased NESTIN staining (though this was
not statistically significant) in Sirt1/ EBs. Consistent
with protein levels, Oct4 mRNA levels decreased more
slowly over time when assessed at 3 days of EB develop-
ment compared to wild-type (Figure S2E), whereas Nestin
expression was not significantly different, at every time
point selected, between genotypes (Figure S2F).
Collectively, these results suggest that SIRT1 defi-
ciency delays, both in vivo and in vitro, the abilityFigure 1. Reprogramming Efficiency and Chimera Generation
(A and C) Representative images of alkaline phosphatase-positive col
(C) MEFs, compared with the relevant wild-type.
(B and D) The relative reprogramming efficiency of Sirt1/ (B) and Si
by counting the colonies and normalizing to viral transduction efficie
Statistical analysis was performed using a two-tailed Student’s t test
(E and F) Representative images of NANOG-positive colonies derived fr
Scale bar represents 500 mm. The relative reprogramming efficiency, e
Error bars represent the SEM. Statistical analysis was performed using
(G and H) Western blot analysis showing the expression of NANOG in Si
control. Five individual iPSC clones per genotype were tested. An ESC
respectively.
(I and J) Tables reporting thedetails of contribution tomouse chimerism
See also Figure S1.
Steof iPSCs to exit pluripotency and commit to ectodermal
lineages.
SIRT1 Is Required for Efficient Telomere Elongation
during Reprogramming
One of the critical events occurring during reprogramming
is a telomerase-dependent telomere elongation, which
gives rise to hyperlong telomeres comparable to those of
ESCs. Because SIRT1 is able to positively regulate telomere
length in MEFs, we asked whether it could also have
a role in telomere elongation during reprogramming. To
test this, we analyzed telomere length in four indepen-
dent iPSC clones per genotype (Sirt1/ versus Sirt1+/+),
compared to the corresponding parental MEFs, using two
experimental approaches.
First, wemeasured the length of telomeric TTAGGG track
using Southern blot-based telomere restriction fragment
(TRF) analysis comparingMEFs (passage 3) with iPSCs (pas-
sage 15). Nuclear reprogramming resulted in telomere
elongation in both Sirt1+/+ and Sirt1/ iPSCs compared
to the corresponding parental MEFs; however, Sirt1/
iPSCs displayed significantly shorter telomeres compared
to wild-type iPSCs (Figure 3A). To validate these results,
we performed a quantitative fluorescence in situ hybridiza-
tion (Q-FISH) on metaphase spreads using a telomere-spe-
cific probe. The frequency distribution of telomere length
confirmed a diminished telomere elongation in Sirt1/
iPSCs compared with Sirt1+/+ controls (Figures 3B and 3E).
This effect became even more apparent when comparing
the absolute lengthening, in kilobases, in Sirt1+/+ versus
Sirt1/ iPSCs after 15 passages in culture (Figure 3F). These
findings support a role for SIRT1 in telomere elongation
during nuclear reprogramming of embryonic fibroblasts.
To further strengthen this conclusion, we also measured
telomere length in Sirt1Super iPSCs (Figures 3C and 3D), and
we observed the opposite trend: the presence of an extra
copy of SIRT1 correlated with greater telomere elongation
upon reprogramming; the quantitative analysis shows anonies derived from the reprogramming of Sirt1/ (A) and Sirt1Super
rt1Super (D) MEFs, expressed as wild-type X-fold, has been calculated
ncy. n, number of independent clones. Error bars represent the SEM.
.
om the reprogramming of Sirt1+/+, Sirt1/, and Sirt1Super MEFs. (E)
xpressed as wild-type X-fold, has been calculated as in (B) and (D).
a two-tailed Student’s t test.
rt1/ (G) and Sirt1Super (H) iPSCs. Tubulin was included as a loading
and an MEF sample were included as positive and negative controls,
obtained frommicroinjection of Sirt1/ (I) and Sirt1Super (J) iPSCs.
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Figure 2. Sirt1/ iPSC-Derived Tera-
tomas Grow Faster than Wild-Type and
Show Delayed Differentiation In Vivo
(A) Representative example of teratomas
generated by Sirt1+/+ and Sirt1/ iPSCs
29 days after injection.
(B) Hematoxylin and eosin-stained tera-
toma sections from both genotypes show
tissues derived from the three germ layers
for both genotypes. Scale bar, 100 mm.
(C and D) Average weight of Sirt1+/+ and
Sirt1/ tumors at the time of excision (C)
and average volume of Sirt1+/+ and Sirt1/
tumors, measured at the indicated day
postinjection (D). n, number of different
tumors per genotype. Error bars represent
the SEM. Statistical analysis was performed
using a two-tailed Student’s t test (C) or
two-way ANOVA (D).
(E, G, and I) Representative areas of Sirt1+/+
(left) and Sirt1/ (right) teratoma sec-
tions 14 days postinjection, stained with
P-H3 (E), OCT3/4 (G), or NESTIN (I) anti-
bodies. Scale bar represents 50 mm.
(F, H, and J) Quantification of P-H3 (F) was
obtained scoring the number of positive
cells in ten random fields. Quantification of
OCT3/4 (H) and NESTIN (J) expression was
obtained measuring throughout the whole
slide the percentage of positive area with
an intensity above an arbitrary threshold by
means of the ImageJ software. n = 3 refers
to three independent wild-type versus three
independent knockout clones injected in
parallel. Error bars refer to SEM. Statistical
analysis was performed using a two-tailed
Student’s t test.
See also Figure S2.
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Figure 3. SIRT1 Is a Positive Regulator of Telomere Elongation Associated with Reprogramming
(A) TRF performed with MEFs (passage 3) derived from one embryo of Sirt1+/+ and two embryos of Sirt1/ genotypes and two independent
iPSC clones (passage 15) obtained from each MEF.
(legend continued on next page)
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to Sirt1+/+ iPSCs (Figure 3G). This result reinforces the
view that SIRT1 plays a role in the elongation of telomere
taking place during the generation of iPSCs by nuclear
reprogramming.
iPSCs show a progressive elongation of telomeres post-
reprogramming; we thus measured telomere length at
different passages of Sirt1+/+ and Sirt1/ iPSCs. Although
we observed the expected elongation with passages of
Sirt1+/+ iPSCs, SIRT1-deficient cells showedonly amild elon-
gation of telomeres upon the same passages (Figure 4A).We
further confirmed these results by Q-FISH analysis in meta-
phase spreads from the same cells (Figures 4B and4C). Inter-
estingly, telomere length in Sirt1/ iPSCs at early passages
(passage5) is comparable to thatofwild-type iPSCs, as deter-
mined both by TRF andQ-FISH (Figures 4A and 4B). Collec-
tively, these results demonstrate that although SIRT1 is not
required for the initial telomere elongation during early re-
programming, it is required for the acquisition of thehyper-
long telomeres during further passaging, an important
feature of the pluripotent nature of iPSCs.
c-MYC-Dependent mTERT Regulation Sustains
Telomere Elongation after Reprogramming
Wenext asked if the effects of SIRT1on telomere lengthdur-
ing reprogramming could be due to a possible misregula-
tion of mTERT expression. Despite significant variability
among clones, western blot analysis of Sirt1+/+ versus
Sirt1/ iPSCs at passage 35, when the divergence in telo-
mere length is more pronounced, showed a clear trend
toward decreased mTERT expression in Sirt1/ iPSCs
compared to wild-type (Figures 5A and 5C, left panels).
The correlation between SIRT1 and telomerase levels was
further confirmed comparing Sirt1+/+ versus Sirt1Super iPSCs,
with SIRT1-overexpressing cells showing an increase in
telomerase expression compared to wild-type cells (Figures
5Aand5C, rightpanels). As expected, thedecreaseobserved
in telomerase abundance in Sirt1/ iPSCs is paralleled by
a consistent difference inmTert transcription (Figure S3A).(B) Telomere length frequency distribution (in kilobases) as determin
independent primary MEFs (passage 3) per genotype, and two independ
the number of independent MEF cultures or iPSCs clones. Error bars repr
Student’s t test.
(C) TRF performed with Sirt1Super iPS (passage 15) and relative wild-ty
included as a reference. Sirt1Super iPSCs were derived from two indepe
iPSC clones).
(D) Telomere length frequency distribution (in kilobases) as determin
independent clones of iPSCs (passage 15) per parental MEF, for a tot
(E) Mean telomere length in Sirt1+/+ and Sirt1/ primary MEFs and i
(F) Average telomere elongation upon reprogramming of Sirt1+/+ and
(G) Mean telomere length in Sirt1+/+ and SirtSuper iPSCs. n indicates t
represent the SEM. Statistical analysis was performed using a two-tai
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oncogene, which is known to regulate telomerase tran-
scription in both human and mouse, has been previously
described (Flores et al., 2006b; Wang et al., 1998). This
prompted us to examine whether decreased telomerase
expression in late-passage Sirt1/ iPSCs correlates with
diminished c-MYC expression. Western blot analysis re-
vealed indeed a reduction in c-MYC expression in late-stage
Sirt1/ iPSCs that paralleled the decrease in telomerase
expression (Figures 5B and 5D, left panels). However, we
did not observe in this case any difference in c-Myc RNA,
pointing to a posttranscriptional regulation of this protein
(Figure S3B). Analogously, in cells overexpressing SIRT1,
c-MYC expression correlated with increased telomerase
expression compared to controls (Figures 5B and 5D, right
panels).
To learnmoreabout themechanismthroughwhichSIRT1
regulates c-MYC expression, we first checked if SIRT1 and
c-MYCphysically interact. Todo this,we transientlyoverex-
pressedmurine SIRT1 and a FLAG-tagged version ofmurine
c-MYC in 293T cells and assayed their coimmunoprecipita-
tion.Wewereable todetect c-MYCuponSIRT1 immunopre-
cipitation and vice versa, supporting a direct interaction
between the two proteins (Figure 5E). This result, together
with the evidence that no significant difference when
comparing c-Myc transcription in Sirt1+/+ and Sirt1/ iPSCs
was observed (Figure S3B), makes it unlikely that SIRT1 reg-
ulates c-Myc transcription through promoter deacetylation.
We then set out to verify if the absence of SIRT1 could affect
c-MYC stability. Upon treatment of Sirt1+/+, Sirt1/, or
Sirt1Super iPSCs with the inhibitor of protein biosynthesis
cycloheximide, we observed a faster decline of c-MYC pro-
tein in the absence of SIRT1 (Figures 5F and 5H), whereas
the presence of an extra copy of Sirt1 significantly prolongs
c-MYC half-life (Figures 5G and 5I).
Taken together, these results suggest that SIRT1 drives
telomere elongation with passages of iPSCs by slowing
down the degradation of c-MYC, which in turn promotes
telomerase expression.ed by Q-FISH on metaphase spreads from Sirt1+/+ and Sirt1/, two
ent clones of iPSCs (passage 15) per each parental MEFs. n indicates
esent the SEM. Statistical analysis was performed using a two-tailed
pe clones. Two samples of each Sirt1/ and relative wild-type were
ndent parental MEFs (two clones each; a total of four independent
ed by Q-FISH on metaphase spreads from Sirt1+/+ and Sirt1Super, two
al of four independent clones.
PSCs.
Sirt1/ MEFs.
he number of independent MEF cultures or iPSCs clones. Error bars
led Student’s t test.
Figure 4. Telomere Elongation after Reprogramming Is Impaired in Sirt1/ iPSCs
(A) TRF analysis of one Sirt1+/+ iPSC clone and one Sirt1/ iPSC clone at increasing passages (p5, p15, p25, and p35). The progressive
telomere lengthening is impaired in the absence of SIRT1. A sample from the parental primary MEF of each clone has been included as a
reference.
(legend continued on next page)
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Expression, Are Not Affected in Sirt1/ iPSCs
SIRT1 deacetylates and directly regulates p53, which has
been linked to reprogramming, tumorigenesis, DNA dam-
age repair, and the recruitment of histone modifiers (Han
et al., 2008).
To exclude the possibility that the phenotype we
observed in Sirt1/ iPSCs might be p53 dependent, we
analyzed the acetylation of p53 at Lys379, a known target
of SIRT1 deacetylase activity, and observed increased levels
in Sirt1/ compared to Sirt1+/+ iPSCs (Figure S3E). How-
ever, no significant increase in total p53 protein levels
(Figures S3C and S3D) or increased expression of the p53
target p21 was detected in Sirt1/ iPSCs (Figure S5F).
SIRT6 is another member of the mammalian sirtuin fam-
ily linked to telomere instability in human cells. SIRT1 is
able to positively regulate SIRT6 in certain tissues (Kim
et al., 2010), raising the possibility that the effect of
SIRT1 deficiency on iPSC telomeres could actually result
from SIRT6 downregulation. However, SIRT6 expression
appears to be increased rather than diminished in Sirt1/
cells (Figures S5G and S5H), ruling out this possibility.
SIRT1 Maintains Genomic Stability in iPSCs
Because SIRT1 has been shown to play important roles in
genome integrity and DNA damage response (Oberdoerffer
et al., 2008), we reasoned that SIRT1 deficiency during re-
programming, and the concomitant telomere elongation
defects in the resulting iPSCs, could render these cells
more prone to chromosomal and/or telomeric aberrations.
To address this, we scored chromosomal aberrations in
Sirt1+/+ and Sirt1/ metaphases using a Cy-3-labeled pep-
tide nucleic acid probe to stain telomeres, focusing on
recurrent aberrations associated with telomere dysfunc-
tion, such as multitelomeric signals (MTSs), chromo-
some/chromatid breaks, and chromosome/chromatid
fusions. Interestingly, we found that MTSs, which are asso-
ciated with replication defects at telomeres (Martı´nez et al.,
2009; Sfeir et al., 2009), were significantly reduced upon
reprogramming in both Sirt1+/+ and Sirt1/ cells (Fig-
ure 6A), suggesting that cells with this type of aberration
are selected against during the reprogramming process. In
agreement with a role for SIRT1 in DNA damage repair,
we found that chromosome/chromatid breaks were
significantly higher in Sirt1/MEFs compared to controls.
Reprogramming significantly reduced chromosome/chro-
matid breaks in both genotypes, although the levels re-(B) Telomere length frequency distribution, obtained from Q-FISH in m
clone at increasing passages (p5, p15, p25, and p35). The results ob
parental primary MEF of each clone has been included as a reference.
(C) Linear regression analysis of telomere elongation with passaging in
iPSC clone (black line). The statistical comparison of the two slopes
698 Stem Cell Reports j Vol. 2 j 690–706 j May 6, 2014 j ª2014 The Authorsmained significantly higher in Sirt1/ than in Sirt1+/+
iPSCs (Figure 6B).
In contrast to MTSs, we observed a subtle increase in
chromosome/chromatid fusions upon reprogramming of
Sirt1+/+ MEFs, which was significantly greater in Sirt1/
iPSCs even at early passages (Figure 6C) and became more
evident with long-term culture. Spectral karyotyping (SKY)
analysis of metaphase spreads from Sirt1+/+ and Sirt1/
iPSCs confirmed that Sirt1/ cells at passage 35 were more
prone to accumulate chromosomal aberrations. In partic-
ular, the analysis of three independent clones per genotype
showed that late-passage Sirt1+/+ iPSCs carried only a few
recurrent aneuploidies (mainly chromosome 8),most likely
due to adaptation to culture, and only a few structural aber-
rations (namelyaduplicationofpart of chromosome14and
a translocation involving chromosome 15 and chromo-
some 8). In marked contrast, the great majority of meta-
phase spreads from Sirt1/ iPSC clones showed additional
aneuploidies and aberrations, most notably Robertsonian
translocation involving both homologs of chromosome 6,
observed in all clones. Also of note, Sirt1/ iPSC clones ex-
hibited clone-specific structural aberrations involving chro-
mosome 8. Figure 6 provides representative karyotyping by
SKY analysis, of Sirt1+/+ (Figure 6D, karyotype formula: 39–
42.XY,+2,+8) versus Sirt1/ iPSCs [Figure 6E, karyotype for-
mula: 35–41.X0,rob(6;6),+8,der(8)T(8;X),+1732]. For the
complete panel of karyotyping in all clones, see the table
in Figure S4, aswell as Figures S4A–S4K. All of these chromo-
somal aberrationsarise specifically in Sirt1/ cellsduring re-
programming, because the parental MEFs display a normal
karyotype (Figures S4L and S4M).
SIRT1 Regulates TERRA Levels and Chromatin
Remodeling Associated with iPSC Generation
Given its histone deacetylase activity, we next tested if
SIRT1 deficiency or overexpression correlates with a dereg-
ulation in TERRA transcription associated with reprogram-
ming. To assess this, we measured TERRA levels in Sirt1+/+
and Sirt1/ iPSCs and their respective parental MEFs. Sur-
prisingly, we observed an increase in baseline levels of
TERRAs in Sirt1/ MEFs, which did not increase upon
reprogramming and compared to levels in Sirt1+/+ iPSCs
(Figures 7A and 7B). On the other hand, Sirt1Super iPSCs ex-
hibited a milder increase in telomeric transcription upon
reprogramming, as compared to Sirt1+/+ iPSCs (Figures 7C
and 7D). Thus, impaired TERRA transcription cannot
explain decreased telomere elongation in Sirt1/ iPSCs,etaphase spreads from one Sirt1+/+ iPSC clone and one Sirt1/ iPSC
tained confirm the tendency observed by TRF. A sample from the
culture, comparing a Sirt1+/+ iPSC clone (gray line) with a Sirt1/
was performed using analysis of covariance.
Figure 5. SIRT1 Regulates mTERT in a c-MYC-Dependent Manner
(A–D) Western blot showing the expression of mTERT (A) and c-MYC (B) in iPSCs with the indicated genotypes (passage 35). Cohesin SMC1
was used as loading control. The quantification of mTERT (C) or c-MYC expression (D) in Sirt1/ (C and D, left panels) or SirtSuper (C and D,
right panels) clones was performed through background subtraction and normalization based on SMC1 expression to correct for differences
(legend continued on next page)
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SIRT1 and Telomere Elongation upon Reprogrammingand interestingly, our data are compatible with a role for
SIRT1 in negatively regulating TERRA expression in differ-
entiated and pluripotent cells.
To specifically address the possibility that SIRT1may also
play a role in the remodeling of telomere chromatin during
reprogramming, we analyzed the abundance of different
histone marks by chromatin immunoprecipitation.
Dot blot analysis using a telomeric repeat-specific probe
showed that TRF1 bound telomeres more abundantly in
iPSCs compared to MEFs, independent of SIRT1 status (Fig-
ure 7E). We also observed a significant increase of HP1g
density at telomeres upon reprogramming, which did not
occur in Sirt1/ iPSCs (Figure 7F), consistent with our pre-
vious observations that SIRT1 deficiency in MEFs results in
lower density of this mark (Palacios et al., 2010). Interest-
ingly, two of the known targets of sirtuin deacetylase
activity, namely H3K9Ac and H4K16Ac acetylation, were
significantly increased in wild-type iPSCs compared to
the parental MEFs (Figures 7G and 7H), consistent with
the stronger expression of SIRT1 in iPSCs (Figure S1C).
However, although H3K9Ac, which is mainly considered
as a target of SIRT6 (Michishita et al., 2008), was similarly
increased in Sirt1+/+ and Sirt1/ iPSCs compared to the
parental MEFs (Figure 7G), H4K16 acetylation was signifi-
cantly more pronounced in Sirt1/ MEFs and iPSCs than
in the wild-type cells (Figure 7H). These results confirm
H4K16Ac as a bona fide target of SIRT1; this mark is signif-
icantly elevated both in Sirt1/ MEFs and iPSCs, suggest-
ing a more ‘‘open’’ chromatin structure associated to
SIRT1 deficiency, in line with increased TERRA transcrip-
tion even in the absence of reprogramming. Of note, the
more open chromatin landscape associated to SIRT1 defi-
ciency is not accompanied by higher telomere elongation,
supporting the idea that the chromatin conformation is
a predisposing, but not determinant, factor for telomere
elongation.DISCUSSION
SIRT1 is a multifunctional protein with roles in several key
cellular processes (Haigis and Sinclair, 2010), and recent
evidence has also implicated this protein in pluripotency.
In particular, SIRT1 is highly expressed in ESCs and down-in loading. A nuclear extract sample obtained frommTert/ MEFs was
per genotype were tested. Error bars refer to SEM. Statistical analysis
(E) Coimmunoprecipitation of SIRT1 and c-MYC in 293T cells transfec
(IP:SIRT1) or a FLAG-specific antibody (IP:FLAG). WB, western blot.
(F–I) c-MYC stability is modulated by SIRT1. Protein synthesis was i
indicated periods of time and analyzed by western blot (F and G). The
whereas an extra copy of Sirt1 increases c-MYC stability (I).
See also Figure S3.
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furthermore, SIRT1 inhibits the p53-mediated repression
of NANOG protein (Han et al., 2008). Here, we demon-
strate that although SIRT1 upregulation occurs upon re-
programming (Figure S1C), it is not required for the process
of reacquiring pluripotency itself. However, we have estab-
lished a role for SIRT1 in postreprogramming events that
are critical for the maintenance of iPSCs. In particular, we
show here that Sirt1/ iPSCs, although exhibiting plurip-
otency features (expression of stemness markers and the
ability to form teratomas and contribute to the develop-
ment of chimeras), fail to efficiently elongate telomeres
after reprogramming and accumulate chromosomal aberra-
tions upon long-term culture.
Telomere elongation is one of the hallmarks of the
reprogramming process, and we previously showed that
this is a two-step process: it starts during reprogramming
and then continues while iPSCs have obtained full plurip-
otent status (Marion et al., 2009). In Sirt1/ cells, the
telomere elongation after reprogramming is significantly
slower, which is consistent with our previous finding
that SIRT1 is recruited to telomeres in iPSCs and positively
regulates telomere length both in MEFs and tissues
(Palacios et al., 2010). Although Sirt1/ MEFs also exhibit
a more pronounced telomere length attrition with cell
generation, the role of SIRT1 in telomere elongation
is more obvious during reprogramming, which involves
a massive net telomere elongation; telomere length defect
is indeed quite subtle in Sirt1/ MEFs, and it is clearly
appreciable only upon the screening of a high number
of samples.
Importantly, we show here that the defective capacity of
Sirt1/ iPSCs to elongate telomeres after reprogramming
is associated with decreased c-MYC protein and lower
expression of telomerase, a known c-MYC target in both
humans and mice (Flores et al., 2006b; Wang et al.,
1998). These findings are consistent with published obser-
vations of the two effects independently in other cell lines.
For example, a recent report showed that the small inter-
fering RNA (siRNA)-mediated downregulation of Sirt1 in
a human thyroid cancer cell line, though not affecting
c-Myc transcription level, produces a robust reduction of
c-MYC protein due to a decrease in its stability (Herranz
et al., 2013).included as a negative control in (A). Four independent iPSC clones
was performed using a two-tailed Student’s t test.
ted with the indicated constructs using a SIRT1-specific antibody
nhibited with 20 mM cycloheximide. Cells were collected after the
decline of c-MYC protein is accelerated in the absence of SIRT1 (H),
Figure 6. Sirt1/ iPSCs Show Higher Chromosomal Instability
(A–C) Quantification of multitelomeric signals (MTS) (A), chromosome breaks (B), and chromosome fusions (C) in Sirt1+/+ and Sirt1/
MEFs (passage 3; two independent cell lines per genotype) and iPSCs (passage 5; two independent clones per each parental MEF). A
(legend continued on next page)
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can also explain the apparent discrepancy between our re-
sults and a recent report showing that siRNA-mediated
knockdown of SIRT1 affects reprogramming efficiency
(Lee et al., 2012); the use of c-MYC as a reprogramming
factor may add a further layer of variability in the expres-
sion of this protein, possibly impacting reprogramming
efficiency.
Interestingly, although it has been described that
Sirt1/ MEFs show in certain conditions an increased
proliferation capacity (Chua et al., 2005; Narala et al.,
2008), Sirt1/ iPSCs do not exhibit any proliferative
advantage over their wild-type counterparts. However,
when microinjected in athymic mice, they form tera-
tomas that grow much faster than Sirt1+/+ xenografts, in
accordance with the view of Sirt1 as a tumor suppressor
gene. Consistently, Sirt1 knockdown in human colorectal
carcinoma cells accelerates tumor xenograft formation
(Kabra et al., 2009).
The higher proliferative rate of Sirt1/ iPSCs in vivo
correlates with a delay of differentiation: while forming
teratomas, Sirt1/ iPSCs retain longer their stemness prop-
erties, thus postponing ectodermal tissue specification. We
could also confirm these findings in vitro, generating EBs
from Sirt1+/+ and Sirt1/ iPSCs. It has been previously
described, in this respect, that SIRT1 is able to favor
neuronal differentiation by repressing theNotch1 pathway
(Hisahara et al., 2008) and promote keratinocyte differenti-
ation in humans (Blander et al., 2009).
Furthermore, here we show that telomeric chromatin
is not properly reprogrammed in SIRT1-deficient iPSCs,
which show a higher than normal density of the
H4K16Ac mark, characteristic of a more open chromatin
structure. Of note, the evidence that Sirt1/ iPSCs fail
to elongate telomeres postreprogramming, despite the
increased ‘‘accessibility’’ of telomeric chromatin, suggests
that telomere elongation, at least in this case, depends pri-
marily on telomerase availability and that a more open
chromatin conformation does not compensate for a lower
level of telomerase.
In agreement with the decreased deacetylation of telo-
meric chromatin, we also see increased TERRA transcrip-
tion in Sirt1/ parental MEFs. We could not detect a
decrease of TERRA transcription in Sirt1/ compared to
Sirt1+/+ iPSCs, but we speculate here that we could probably
detect it in Sirt1/ iPSCs at late passages, when the defectsrepresentative image of every chromosomal aberration is shown. Erro
two-tailed Student’s t test.
(D and E) SKY analysis of metaphase spreads from Sirt1+/+ and Sir
left to right by DAPI staining, the display color, and the classi
35–41.X0,rob(6;6),+8,der(8)T(8;X),+1732 (E).
See also Figure S4.
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observations are particularly interesting, because they
open the possibility that other mechanisms, besides the
c-MYC-induced mTert downregulation, could contribute
to slow down telomere lengthening in Sirt1/ cells;
mounting evidence, reviewed in Maicher et al. (2012), cor-
relates increased transcription of TERRAs with telomere
shortening. In Sirt1Super iPSCs, this correlation is already
evident at passage 15.
Finally, it is also plausible that SIRT1 deficiency may
impair proper telomere elongation in iPSCs through
deregulation of telomere recombination in a telomerase-
independent manner. Interestingly, recombination-medi-
ated telomere elongation associated with the early stages
of embryo development has been described (Liu et al.,
2007).
In line with the role of SIRT1 in recombination, Sirt1/
iPSCs show enhanced genome instability, as indicated
by a significant increase in chromosome breaks and chro-
mosomal/chromatid fusions in Sirt1/ compared with
Sirt1+/+ iPSCs. It is worth mentioning, in this respect, that
siRNA depletion of TERRA has also been linked to an in-
crease in aberrations in metaphase telomeres (Deng et al.,
2009). Extensive genomic instability, leading to the appear-
ance of chromosome breaks, unequal chromosome segre-
gation, and aneuploidy, has also been reported both in
SIRT1-deficient day 9.5 embryos and MEFs (Wang et al.,
2008). Interestingly, we found that upon long-term cul-
ture, Sirt1/ iPSCs, in addition to a few aneuploidies
shared with the Sirt1+/+ iPSCs (mainly trisomy 8, described
as one of themost recurrent numerical aberration inmouse
ESCs/iPSCs; Chen et al., 2011; Liu et al., 1997), display a
recurrent chromosome aberration, namely the Robert-
sonian translocation of chromosome 6. It would be inter-
esting to investigate if this translocation is somehow
positively selected, maybe because it engenders the dosage
increase of genes conferring a growing advantage (Nanog,
Kras, or Raf1, for instance).
Given the broad range of SIRT1 target proteins, many
putative players could be possibly involved, directly or
indirectly, in the abnormalities we observe in Sirt1/
iPSCs. For example, SIRT1 deacetylates p53 (Han et al.,
2008), preventing its transactivation and translocation
into the nucleus, and in specific conditions positively
regulates SIRT6, another member of mammalian sir-
tuin family, whose deficiency correlates with telomericr bars represent the SEM. Statistical analysis was performed using a
t1/ iPSCs (passage 35). Each chromosome is represented from
fication pseudocolor. Karyotype formulas: 3942.XY,+2,+8 (D);
Figure 7. SIRT1 Is Involved in Regulation
of TERRA Transcription and in the
Reprogramming of Telomeric Chromatin
(A and C) Expression of TERRA in the indi-
cated cells types as measured by dot blot
hybridization with a [UUAGGG]n probe. 18S
ribosomal subunit was used as a loading
control.
(B and D) Quantification of TERRA levels
reported in (A) and (C), respectively. Two
independent MEFs per genotype (n = 2) and
two independent iPSC clones per parental
MEF (n = 4) were used. Error bars represent
the SEM. Statistical analysis was performed
using a two-tailed Student’s t test.
(E–H) Quantification of immunoprecipi-
tated telomeric repeats with the antibodies
indicated in each panel. Values were ob-
tained after normalization to DNA input
signal (anti-TRF1 and anti-HP1g), to both
DNA input signal and histone H3 abundance
(anti-H3K9Ac), and to both DNA input
signal and histone H4 abundance (anti-
H4K16Ac). Error bars represent the SEM; n
indicates the number of independent
clones tested. Statistical analysis was per-
formed using a two-tailed Student’s t test.
MEF passage number = 3; iPSC passage
number = 15.
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2008). Deregulation of p53 and/or SIRT6 could result in
genomic instability, telomere fragility, and abnormal chro-
matin structure. However, in Sirt1/ iPSCs, we could not
observe hyperexpression of p53 or downregulation of
SIRT6.
In conclusion, this report demonstrates a role of SIRT1
deacetylase in the maintenance of ‘‘good-quality’’ iPSCs,Stewith proper telomere elongation, TERRA transcription,
telomeric chromatin remodeling, and genome integrity.EXPERIMENTAL PROCEDURES
Generation of Mouse iPSCs
Reprogramming of primaryMEFs (passage 2) was performed as pre-
viously described (Marion et al., 2009), following modifications ofm Cell Reports j Vol. 2 j 690–706 j May 6, 2014 j ª2014 The Authors 703
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reprogramming process was assessed 2 weeks postinfection by
scoring, by means of an ImageJ software routine, the number of
iPSC colonies obtained at day 14 postinfection, either alkaline
phosphatase stained (Alkaline Phosphatase Detection kit, Milli-
pore) or NANOG stained (antibody #8822 1:250, Cell Signaling).
This count was normalized to the total number of cells infected,
obtained by flow cytometry analysis of an identical sample
infected with the three factors plus GFP. Colonies were picked
after 2 weeks and expanded on feeder fibroblasts using standard
procedures. All procedures performed on mice were revised and
approved by the institutional ethical committee.Differentiation Assay through EB Aggregation
Four clones of each Sirt1+/+ and Sirt1/ iPSCs on feeder layers were
trypsinized and resuspended at a density of 2.53 106/ml in LIF-free
medium. A total of 100 hanging drops of 5,000 cells (20 ml) per
clone were suspended for 48 hr and transferred to a nonadherent
Petri dish. To perform immunohistochemistry, EBswere embedded
in 5% gelatin and formalin fixed.Histopathology and Immunohistochemistry
After excision, teratomas were fixed in formalin, embedded in
paraffin and dissected at a thickness of 5 mm. For pathological
examination sections were stained with hematoxylin and eosin,
according to standard procedures. For immunohistochemical
analysis, sections were processed with antibodies against mouse
Phospho(Ser10)-histone 3 (Millipore, 06-570), OCT3/4 (Santa
Cruz sc-9081), and NESTIN (Millipore MAB 353).Quantification of Immunohistochemistry Staining
To quantify P-H3-positive cells in teratoma sections, ten pictures
of random fields were taken from one section per clone (n = 3
per genotype) and the number of positive cells manually counted.
To quantify the percentage of positive area in sections stained for
OCT4 or NESTIN, one section of each teratoma (n = 3 per geno-
type) was divided into a sufficient number of pictures in order to
cover it all (using the Pannoramic Viewer software). In every pic-
ture, the percentage of positive area was scored through an ImageJ
software routine. The percentage of positive area was then calcu-
lated for the whole section.
To quantify the percentage of positive area in EB sections stained
for OCT4 or NESTIN, three pictures per clone (n = 12 per genotype)
were taken using the Pannoramic Viewer software. Positive area
and total EB area were scored in every picture through an ImageJ
software routine. Percentage of positive area was calculated per
every picture and then grouped per genotype.Coimmunoprecipitation c-MYC-FLAG-SIRT1
293T cells were transfected with 4 mg of murine Sirt1 or a FLAG-
Tagged c-Myc-expressing vectors. After 72 hr, the cells were lysed,
sonicated, and precleared. A total of 1 mg of every sample was
immunoprecipitated with a SIRT1 antibody (Abcam ab12193),
followed by the capture of the complex by a G-Ultralink Resin
beads (Thermo Scientific, #53125) or an anti-FLAG M2 affinity
gel (Sigma, #A2220).704 Stem Cell Reports j Vol. 2 j 690–706 j May 6, 2014 j ª2014 The AuthorsSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
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